Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 5 other studies
1,145people with heart failure, in this paper
The trial randomly assignedassigned by chance
semaglutide
placebo
Raised 6-minute walk distance+14.6
randomisedthe abstract, start to end
… at 20 weeks (treatment difference 14.6 m [95% CI: 8.6-20.7 m]; P < 0.0001) that was maintained at 52 weeks (treatment difference 17.1 m [95% CI: 9.2-25.0 m]; P < …
← favours treatmentfavours comparator →
could be chance6-minute walk distance (6MWD)semaglutide vs placebo
14.68.60–20.7
6-minute walk distance (6MWD)semaglutide vs placebo
17.19.20–25.0
GLP-1 receptor agonistsCardiac & vascular function
GLP-1 receptor agonists × cardiac & vascular functionhelps?mixed
unlikelylikely
0.500.50 without it
← favours comparatorfavours treatment →
1 / 6